| Home | E-Submission | Sitemap | Editorial Office |  
top_img
   
ORIGINAL ARTICLE 2024 January 18
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors
Purpose This study aimed to report the results from an early-phase study of rivoceranib, an oral tyrosine kinase inhibitor highly selective for vascular endothelial growth factor receptor 2, in patients with advanced solid tumors. Materials and Methods In this open-label, singl...
ORIGINAL ARTICLE 2024 January 8
Analytical and Clinical Validation of a Highly Sensitive NGS-Based ctDNA Assay with Real-World Concordance in Non–Small Cell Lung Cancer
Purpose There have been needs to improve the sensitivity of liquid biopsy. This report aims to report the analytical and clinical validation of a next-generation sequencing (NGS)–based circulating tumor DNA (ctDNA) assay. Materials and Methods Analytical validation was conduct...
ORIGINAL ARTICLE 2024 January 30
Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non–Small Cell Lung Cancer: Single-Institution Experience
Purpose Exon 20 insertion mutations (E20ins) in epidermal growth factor receptor (EGFR) or human epidermal growth factor receptor 2 (HER2) in non–small cell lung cancer (NSCLC) patients has become more important with emergence of novel agents targeting E20ins. Materials and Me...
Current Issue
Volume 56(3); Jul 2024
Volume 56(2); April 2024
Volume 56(1); January 2024
RSS feed
  • Most-read are based on citations from 2022 ~ 2024.
  • Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2019 ( 20650 times )
    Mee Joo Kang, Young-Joo Won, Jae Jun Lee, Kyu-Won Jung, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2022;54(2):330-344.   Published online March 16, 2022    DOI: https://doi.org/10.4143/crt.2022.128
                            Supplementary         Web of Science 163  Crossref 185
    Prediction of Cancer Incidence and Mortality in Korea, 2022 ( 12132 times )
    Kyu-Won Jung, Young-Joo Won, Mee Joo Kang, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
    Cancer Res Treat. 2022;54(2):345-351.   Published online March 21, 2022    DOI: https://doi.org/10.4143/crt.2022.179
                               Web of Science 55  Crossref 50
    Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer ( 11053 times )
    Joel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei
    Cancer Res Treat. 2022;54(2):315-329.   Published online February 18, 2022    DOI: https://doi.org/10.4143/crt.2022.078
                               Web of Science 20  Crossref 22
    General
    Engineering a High-Affinity PD-1 Peptide for Optimized Immune Cell-Mediated Tumor Therapy ( 9785 times )
    Yilei Chen, Hongxing Huang, Yin Liu, Zhanghao Wang, Lili Wang, Quanxiao Wang, Yan Zhang, Hua Wang
    Cancer Res Treat. 2022;54(2):362-374.   Published online August 3, 2021    DOI: https://doi.org/10.4143/crt.2021.424
                            Supplementary         Web of Science 4  Crossref 5
    Lung and Thoracic cancer
    A Phase I/IIa Randomized Trial Evaluating the Safety and Efficacy of SNK01 Plus Pembrolizumab in Patients with Stage IV Non-Small Cell Lung Cancer ( 9773 times )
    Eo Jin Kim, Yong-Hee Cho, Dong Ha Kim, Dae-Hyun Ko, Eun-Ju Do, Sang-Yeob Kim, Yong Man Kim, Jae Seob Jung, Yoonmi Kang, Wonjun Ji, Myeong Geun Choi, Jae Cheol Lee, Jin Kyung Rho, Chang-Min Choi
    Cancer Res Treat. 2022;54(4):1005-1016.   Published online December 3, 2021    DOI: https://doi.org/10.4143/crt.2021.986
                            Supplementary         Web of Science 6  Crossref 6
    Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2020 ( 9743 times )
    Mee Joo Kang, Kyu-Won Jung, So Hyun Bang, Seo Hyun Choi, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo, The Community of Population-Based Regional Cancer Registries*
    Cancer Res Treat. 2023;55(2):385-399.     DOI: https://doi.org/10.4143/crt.2023.447
                            Supplementary         Web of Science 40  Crossref 58
    Recommendations for the Use of Next-Generation Sequencing and the Molecular Tumor Board for Patients with Advanced Cancer: A Report from KSMO and KCSG Precision Medicine Networking Group ( 9177 times )
    Shinkyo Yoon, Miso Kim, Yong Sang Hong, Han Sang Kim, Seung Tae Kim, Jihun Kim, Hongseok Yun, Changhoon Yoo, Hee Kyung Ahn, Hyo Song Kim, In Hee Lee, In-Ho Kim, Inkeun Park, Jae Ho Jeong, Jaekyung Cheon, Jin Won Kim, Jina Yun, Sun Min Lim, Yongjun Cha, Se Jin Jang, Dae Young Zang, Tae Won Kim, Jin Hyoung Kang, Jee Hyun Kim
    Cancer Res Treat. 2022;54(1):1-9.   Published online December 13, 2021    DOI: https://doi.org/10.4143/crt.2021.1115
                               Web of Science 10  Crossref 11
    Prediction of Cancer Incidence and Mortality in Korea, 2023 ( 9117 times )
    Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
    Cancer Res Treat. 2023;55(2):400-407.     DOI: https://doi.org/10.4143/crt.2023.448
                               Web of Science 16  Crossref 17
    General
    Functional Impairments in the Mental Health, Depression and Anxiety Related to the Viral Epidemic, and Disruption in Healthcare Service Utilization among Cancer Patients in the COVID-19 Pandemic Era ( 8533 times )
    Kyumin Kim, Harin Kim, Joohee Lee, Inn-Kyu Cho, Myung Hee Ahn, Ki Young Son, Jeong Eun Kim, Hee Jeong Kim, Sang Min Yoon, So Hee Kim, Moon Jung Kwon, Hwa Jung Kim, Su-Jin Koh, Seyoung Seo, Seockhoon Chung
    Cancer Res Treat. 2022;54(3):671-679.   Published online September 17, 2021    DOI: https://doi.org/10.4143/crt.2021.585
                               Web of Science 16  Crossref 19
    Skin cancer
    Incidence and Survival Rates of Cutaneous Melanoma in South Korea Using Nationwide Health Insurance Claims Data ( 8526 times )
    TaeHo Kim, Siyeong Yoon, Dong-Eun Shin, Sang Cheol Lee, Jisu Oh, So-Young Lee, Do Kyung Kim, Segi Kim, Bosung Jung, Minsup Kim, Soonchul Lee
    Cancer Res Treat. 2022;54(3):937-949.   Published online September 30, 2021    DOI: https://doi.org/10.4143/crt.2021.871
                            Supplementary         Web of Science 4  Crossref 6
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Journal Impact Factor 4.1
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    Metadata
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association.                 Developed in M2PI